EC approves aclidinium bromide

The European Commission approved an MAA from Almirall S.A. (Madrid:ALM) for Bretaris/ Eklira Genuair aclidinium bromide as maintenance bronchodilator treatment to relieve symptoms in patients with chronic obstructive pulmonary disease (COPD). Almirall plans to launch the product this year with co-commercialization partner Menarini Group (Florence, Italy). ...